Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementia
Year: 2023
Type: article
Study design: Observational Study
Abstract: Background: Frontotemporal dementia is the second most common form of early onset dementia (< 65 years). Despite this there are few known disease modifying factors. The anterior cingulate is a focal point of pathology in behavioural variant frontotemporal dementia. Sulcation of the anterior cingulate is denoted by the presence of a paracingulate sulcus, a tertiary sulcus developing, where present during the third gestational trimester and remaining stable throughout life. This study aims to examine the impact of right paracingulate sulcal presence on the expression and prognosis of behavioural variant Frontotemporal Dementia. Methods: This retrospective analysis drew it's population from two clinical samples recruited from memory clinics at University Hospitals in The United States of America and The Netherlands. Individuals with sporadic behavioural variant Frontotemporal Dementia were enrolled between 2004 and 2022 and followed up for an average of 7.71 years. T1-MRI data were evaluated for hemispheric paracingulate sulcal presence in accordance with an established protocol by two blinded raters. Outcome measures included age at onset, survival, cortical thickness, and Frontotemporal Lobar Degeneration-modified Clinical Dementia Rating determined clinical disease progression. Results: = 0.7). Right paracingulate sulcal presence was not associated with baseline cortical thickness. Conclusion: Right paracingulate sulcal presence is associated with disease expression and survival in sporadic behavioural variant Frontotemporal Dementia. Findings provide evidence of neurodevelopmental brain reserve in behavioural variant Frontotemporal Dementia which may be important in the design of trials for future therapeutic approaches.
Source: Brain Communications
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,443
Funders: University of Pennsylvania, Cure Alzheimer's Fund, Parkinson's Foundation, Australian Government, Lunds Universitet, Svenska Sällskapet för Medicinsk Forskning, Hjärnfonden, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, Skånes universitetssjukhus, National Institutes of Health, Parkinsonfonden, National Institute on Aging
Awards: G1457535256, G2043619954, G3718618909, Novel biomarkers for improving diagnostics, prognostics, and treatments of Alzheimer’s disease, G4028979961, G5184609404, Microscopic and Large-Scale Networks of Molecular Pathology in Frontotemporal Lobar Degeneration, G5524304478, G5585422332, G6066643948, G6210124294, G7153071485, G7278021877, 3rd International Conference on Tomography of Materials and Structures, Multidimensional Approaches to Understanding Consequences and Mechanisms of Apathy in Frontotemporal Degeneration, Scalable Label-free electric detection of pathogens
OpenAlex ID: W4387446158
